ArticleResearch square2026

Inhibition of SIK2 and SIK3 induces adaptive ER-phagy and creates a therapeutic vulnerability in ovarian cancer.

Zhen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.